# Borosil Scientific share price today (Borosil Scientific Ltd, NSE: BOROSCI)

> Borosil Scientific share price today: ₹106.07 at the NSE close on 3 November 2026, down 22.2% in a year. Borosil Scientific (NSE: BOROSCI) is worth ₹941 crore, trades at a P/E of 20.1 and has closed between ₹100.97 and ₹168.58 over the past 52 weeks. > Borosil Scientific Ltd's earnings have grown faster than its share price. Earnings per share grew +29.2% in a year while the price moved −22.2%. BOROSCI · Glass & Glass Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/borosil-scientific-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from fewer quarters than usual
- Price: ₹106.07 (−22.2% in a year)
- P/E: 20.1× (lower than 99% of the last 2.4 years)
- Revenue (Sep 2026): ₹115 Cr (+7.5% on a year ago)
- Profit (Sep 2026): ₹5.3 Cr (+86.6% on a year ago)
- Operating margin: 9.3% (+1.8 points on a year ago)
- ROCE: 12%, FY26
- ROIC: 12.8%, against a 12.0% cost of capital: +0.8 points

The main question: yearly earnings per share moved +29.2% while the share price moved −22.2%. ## What is the Borosil Scientific share price today? Borosil Scientific Ltd's share price was ₹106.07 at the close on 3 November 2026. It has been falling for 5 weeks. That is 17.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹101 and ₹169, and at that close it sat 8% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 15 weeks running. Over the last 2.4 years the share price moved −32% while the NIFTY 500 moved +0%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 24 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Borosil Scientific this quarter? 2. Revenue up on a year earlier for 5 quarters in a row In the September 2026 quarter revenue was ₹115 crore, +7.5% on a year earlier. 3. Profit up on a year earlier for 4 quarters in a row In the September 2026 quarter profit was ₹5 crore, +86.6% on a year earlier. ## What are Borosil Scientific's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Borosil Scientific reported revenue of ₹115 crore, up 7.5% from ₹107 crore a year earlier, and a profit of ₹5.30 crore, up 86.6% from ₹2.84 crore. ### Borosil Scientific results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹115 crore | ₹107 crore | +7.5% |
| Profit | ₹5.30 crore | ₹2.84 crore | +86.6% |
| Earnings per share | ₹0.60 | ₹0.32 | +87.5% |
| Operating margin | 9.3% | 7.5% | +1.8 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Borosil Scientific share price history? Borosil Scientific closed at ₹106.07 on 3 November 2026, down 22.2% from ₹136.40 a year earlier (31 October 2025). Its highest weekly close since June 2024 was ₹213.95 on 28 June 2024. ### Borosil Scientific share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹106.15 | −0.1% |
| 1 month ago · 1 Oct 2026 | ₹112.72 | −5.9% |
| 6 months ago · 30 Apr 2026 | ₹114.86 | −7.7% |
| 1 year ago · 31 Oct 2025 | ₹136.40 | −22.2% |
| Earliest weekly close in our records · 7 Jun 2024 | ₹156.70 | −32.3% |
| Highest weekly close since June 2024 · 28 Jun 2024 | ₹213.95 | −50.4% |
| Lowest weekly close since June 2024, also the 52-week low · 27 Mar 2026 | ₹100.97 | +5.1% |
| 52-week high (weekly close) · 1 Jul 2026 | ₹168.58 | −37.1% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (130 weekly closes from 7 June 2024 to 3 November 2026.)

## What is the latest news on Borosil Scientific? 3 Nov 2026: Borosil Scientific closed at ₹106.07, down 0.1% on the week and down 5.9% on the month. Results for July to September 2026: Revenue up 7.5% and profit up 86.6% on a year earlier. ## What dividend does Borosil Scientific pay? Borosil Scientific has paid no dividend on the NSE since its first NSE close in our records (7 June 2024), the start of the period we checked. No. Borosil Scientific Ltd paid out 0% of its profit as dividends in each of its last 3 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Borosil Scientific management say on the latest results call? Borosil Scientific's management made 0 promises we could check against what it later reported. (Our read after the latest results, written 14 June 2026.)

## Which stock lists is Borosil Scientific on? Borosil Scientific is not on any of our India lists this week. ## Is Borosil Scientific profitable? Borosil Scientific Ltd earned ₹5.3 Cr of net profit in the Sep 2026 quarter, +86.6% on the same quarter a year earlier. Full-year FY26 profit was ₹35.0 Cr. Over 2 years profit has grown 23.4% a year on average. That is 4.6% of the quarter's revenue. The same quarter a year earlier earned ₹2.8 Cr. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹35.0 Cr (+29.6% on the year before). Why profit moved: revenue changed +7.5% on a year earlier and the margin moved +1.8 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +135.3% and revenue +12.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Borosil Scientific make, and is it growing? Borosil Scientific Ltd reported ₹115 Cr of revenue in the Sep 2026 quarter, +7.5% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 2 years it has grown 8.6% a year on average. The last full year, FY26, came in at ₹462 Cr. Why this happened. Pharma Packaging (glass vials, ampoules) contributed ₹70.3Cr in FY26, FDA/GMP certified facility serving Indian pharma exports. Global pharma packaging market growing at ~6% CAGR. 'China Plus One' supply chain shift creates tailwinds as Indian pharma manufacturers prefer domestic glass packaging. Anti-dumping probes on Chinese borosilicate glass (C016) could tighten import competition. The last four reported quarters add to ₹486 Cr. FY26 revenue was ₹462 Cr, +6.5% on the year before. Recent pace: the last four quarters grew +12.2% on average, against 8.6% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +12.1%, against +7.3% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +295.5%, against +25.4% a year (accelerating). ## How much of every ₹100 of sales does Borosil Scientific keep? Borosil Scientific Ltd's operating margin was 9.3% in the Sep 2026 quarter, 1.8 percentage points higher than the same quarter a year ago. Across 3 years it has been between 12.0% and 14.0%. The latest quarter is below every full year in that period. Why this happened. Scientific glass manufacturing has high fixed costs (furnace, energy, skilled labor). Revenue grew 21% YoY in Q4 FY26 (₹143Cr vs ₹118Cr implied) while OPM expanded from 13% to 22%, classic fixed-cost leverage. As revenue scales toward ₹550-600Cr over FY27-FY28, the 13% mid-cycle OPM should structurally improve toward 15-16%. Why the margin moved: operating margin changed +1.8 percentage points on the year while gross margin changed +1.9 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Borosil Scientific's profit turning into cash? Over the last 3 years, 227% of Borosil Scientific Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹43.0 Cr of operating cash against ₹35.0 Cr of profit. After ₹29.0 Cr of spending on assets, ₹14.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 227% of profit came in as cash: the cash cycle stayed about the same between FY24 and FY26, so the cash follows profit, not the cycle. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Borosil Scientific's cash go? Borosil Scientific Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 193 days in FY26, down from 200 days in FY24. It spent ₹42.0 Cr on assets over the last 2 years. Customers take 60 days to pay, and stock sits for 226 days on average. At FY26 sales of ₹462 Cr, each day of that cycle ties up about ₹1.3 Cr, so roughly ₹244 Cr is tied up in the business at any time. FY26: customers took 60 days to pay and stock sat for 226 days, about 7.4 months of sales sitting as stock, for a full cycle of 193 days, shorter than FY24's 200. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 226 days. Customers pay about 60 days after that. Suppliers are paid at 93 days. Together that makes the 193-day cycle. Spending on assets: ₹42.0 Cr over the last 2 years, against ₹37.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹9.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Borosil Scientific's P/E ratio, and how does it compare with its own history? Borosil Scientific Ltd's P/E is 20.1×, about the lowest it has ever been. Its usual P/E (the middle reading) is 49.2×, over 2.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹5.13. Why the multiple is where it is: over the past year earnings per share moved +29.2% while the price moved −22.2%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the Borosil Scientific share price assume? Worked out from its price on 20 July 2026, Borosil Scientific Ltd's share price assumed profit growth of about 24.5% a year. Over the past 2 years its profit actually grew 23.4% a year. Today its P/E is 20.1×, lower than 99% of its own last 2.4 years. This is a one-day reading, taken on 20 July 2026. Every other number on this page, the multiple included, uses the latest price as of 3 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the Borosil Scientific business getting better or worse? Borosil Scientific Ltd's business is turning around. Profit growth has swung from −42.1% at its low to +295.5%, improving for 3 quarters in a row, with ROCE falling at 7.0%. This is based on 9 quarters of 3 measures, with some gaps. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## What is the Borosil Scientific story, and has it been checked? Borosil Scientific Ltd's story is not scored yet against the checks our research set on 14 June 2026. Where it sits in its own cycle: Not stated in the research file. Still open: Chinese import competition

What is proven. See the research file

What is not proven yet. Chinese import competition

The test written in advance. Chinese import competition. Measured by: Chinese import competition Anti-dumping duty imposed → risk reduces. Duty rejected or no action → reassess structural pricing power thesis. by the next result. The test written in advance. Q4 FY26 PAT spike driven by tax one-off. Measured by: Q4 FY26 PAT spike driven by tax one-off Q1 FY27 PAT sustains ≥₹15Cr on organic margin recovery → confirms underlying earnings power. by the next result. What the surface reading misses. Here, Q4 FY26 PAT includes an ₹8Cr one-off tax benefit (C009). Still at or below the 10y median of 52.3x. The 0th percentile (33.8x on headline EPS) is partly a statistical artefact of the one-off-inflated FY26 EPS. What the surface reading misses. The surface reading is: OPM highly volatile (5-22% range), quality concern, business has low earnings visibility The research reads it further: The volatility pattern shows clear seasonality: Q4 (Mar) is consistently the strongest quarter (Mar2024=15.8%, Mar2025=12.8%, Mar2026=22.4%), Q1 (Jun) is weakest (Jun2024=9.4%, Jun2025=5.1%). This is operating deleverage on the seasonally softer quarter, not structural margin erosion. The trend within each fiscal year is recovery from trough. Lever 1 · Operating leverage: building. Scientific glass manufacturing has high fixed costs (furnace, energy, skilled labor). Revenue grew 21% YoY in Q4 FY26 (₹143Cr vs ₹118Cr implied) while OPM expanded from 13% to 22%, classic fixed-cost leverage. As revenue scales toward ₹550-600Cr over FY27-FY28, the 13% mid-cycle OPM should structurally improve toward 15-16%. What proves it keeps working: Operating leverage on fixed-cost lab glass manufacturing. It stops working if Anti-dumping duty imposed → risk reduces. Duty rejected or no action → reassess structural pricing power thesis. Sources: our stock research file (14 June 2026) · quarterly results through Sep 2026. The story check is re-scored every results season; the record below never changes. ## How much does Borosil Scientific earn on its capital? Borosil Scientific Ltd earned a ROCE of 12% in FY26. Its return on capital used (ROIC) is 0.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 7.6% net margin and 0.86× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 7.6% net margin × 0.86× asset turnover × 1.22× leverage (assets divided by equity) ≈ 8.0% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 12.8% − 12.0% = +0.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 12.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 11.5%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Borosil Scientific have too much debt? Borosil Scientific Ltd has total debt of ₹6.0 Cr against shareholder equity of ₹452 Cr as of Sep 2026, so its debt is 0.01× its equity, which is very little. Year by year, that ratio went from 0.49 in FY23 to 0.02 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Borosil Scientific shareholding pattern? No group of Borosil Scientific Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.3 points over the same period, to 0.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +0.4 points over 8 quarters, to 68.3%; Domestic institutions: +0.3 points over 8 quarters, to 0.3%; Foreign institutions: −0.2 points over 8 quarters, to 0.1%. ## How far is Borosil Scientific from balance-sheet trouble? For Borosil Scientific Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Borosil Scientific rank in its industry? 59.9 out of 100, rank 3 of 6 in Glass & Glass Products, with 78% of the evidence available. Borosil Scientific Ltd scores 59.9 out of 100 against the 6 companies it is compared with in Glass & Glass Products, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 26.6 + 9.8 + 15.3 + 8.2 = 59.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Borosil Scientific compared with? Borosil Scientific ranks 3 of 6 Glass & Glass Products companies on the 4-Factor Sector Score, with 59.9 out of 100. 1. [Sejal Glass Ltd](https://www.sectoralpha.in/stocks/sejal-glass-ltd) SEJALLTD · turning · Most evidence points up · 90% evidence 71.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.5/35 · Revenue 51.8% · Profit 94.7% · Operating margin change 1 points · 100% evidence Capital efficiency 16.4/25 · ROCE 18.6% · Operating margin 17% · 100% evidence Valuation 12.6/20 · P/E 23.4× · PEG n/a · 50% evidence Relative strength 20.0/20 · Lead over its industry 5.7% · Lead over NIFTY 500 11.4% · 1 year -17.4% · 100% evidence · 3 of 12 weeks ahead Exact sum: 22.5 + 16.4 + 12.6 + 20 = 71.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Empire Industries Ltd](https://www.sectoralpha.in/stocks/empire-industries-ltd) EMPIND · quiet · Evidence leans up · 81% evidence 61.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue 8.1% · Profit 60% · Operating margin change 2 points · 88% evidence Capital efficiency 12.9/25 · ROCE 18% · Operating margin 11% · 100% evidence Valuation 17.2/20 · P/E 10× · PEG 1.2 · 100% evidence Relative strength 10.4/20 · Lead over its industry n/a · Lead over NIFTY 500 0.6% · 1 year -12.1% · 25% evidence · 1 of 5 weeks ahead Exact sum: 20.9 + 12.9 + 17.2 + 10.4 = 61.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. Borosil Scientific Ltd this page BOROSCI · quiet · Evidence leans up · 78% evidence 59.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.6/35 · Revenue 12.1% · Profit 100% · Operating margin change 1.8 points · 100% evidence Capital efficiency 9.8/25 · ROCE 12.1% · Operating margin 9.3% · 100% evidence Valuation 15.3/20 · P/E 19.3× · PEG 0.56 · 65% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.3% · 1 year -25.4% · 25% evidence · 1 of 12 weeks ahead Exact sum: 26.6 + 9.8 + 15.3 + 8.2 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Saint-Gobain Sekurit India Ltd](https://www.sectoralpha.in/stocks/saint-gobain-sekurit-india-ltd) SEKURITIND · quiet · Evidence leans up · 81% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 16.7% · Profit 13.7% · Operating margin change -4.9 points · 88% evidence Capital efficiency 16.7/25 · ROCE 24% · Operating margin 16.3% · 100% evidence Valuation 17.9/20 · P/E 20.9× · PEG 0.66 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -2.7% · 1 year -12.1% · 25% evidence · 0 of 5 weeks ahead Exact sum: 13.9 + 16.7 + 17.9 + 9.2 = 57.7 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 5. [Borosil Renewables Ltd](https://www.sectoralpha.in/stocks/borosil-renewables-ltd) BORORENEW · quiet · Evidence leans down · 75% evidence 49.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 11.8% · Profit 100% · Operating margin change -5 points · 95% evidence Capital efficiency 18.2/25 · ROCE 25.3% · Operating margin 26% · 76% evidence Valuation 10.9/20 · P/E 13.8× · PEG n/a · 15% evidence Relative strength 0.0/20 · Lead over its industry -25.3% · Lead over NIFTY 500 -21.1% · 1 year -39.9% · 100% evidence · 1 of 12 weeks ahead Exact sum: 20.5 + 18.2 + 10.9 + 0 = 49.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Asahi India Glass Ltd](https://www.sectoralpha.in/stocks/asahi-india-glass-ltd) ASAHIINDIA · leader · Evidence leans down · 81% evidence 40.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.9/35 · Revenue 10.3% · Profit 26.5% · Operating margin change 7 points · 88% evidence Capital efficiency 10.3/25 · ROCE 11.5% · Operating margin 23% · 100% evidence Valuation 1.9/20 · P/E 51.7× · PEG 9.1 · 100% evidence Relative strength 11.6/20 · Lead over its industry n/a · Lead over NIFTY 500 3.6% · 1 year -1.9% · 25% evidence · 10 of 12 weeks ahead Exact sum: 16.9 + 10.3 + 1.9 + 11.6 = 40.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Glass & Glass Products](https://www.sectoralpha.in/sectors/glass-glass-products), all 6 compared on one page. ## Which companies are close to Borosil Scientific in size? Borosil Scientific is the 4th largest of 6 Glass & Glass Products companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Asahi India Glass, Borosil Renewables and Saint-Gobain Sekurit India. Just below it: Sejal Glass and Empire Industries. ### Glass & Glass Products companies close in size

1. [Asahi India Glass Ltd](https://www.sectoralpha.in/stocks/asahi-india-glass-ltd) ₹23,070 crore
2. [Borosil Renewables Ltd](https://www.sectoralpha.in/stocks/borosil-renewables-ltd) ₹5,691 crore
3. [Saint-Gobain Sekurit India Ltd](https://www.sectoralpha.in/stocks/saint-gobain-sekurit-india-ltd) ₹927 crore
4. Borosil Scientific Ltd ₹905 crore
5. [Sejal Glass Ltd](https://www.sectoralpha.in/stocks/sejal-glass-ltd) ₹882 crore
6. [Empire Industries Ltd](https://www.sectoralpha.in/stocks/empire-industries-ltd) ₹562 crore

[All 6 Glass & Glass Products companies, largest first](https://www.sectoralpha.in/sectors/glass-glass-products#all-companies)

### Companies close in size in other industries

1. [Apex Frozen Foods Ltd](https://www.sectoralpha.in/stocks/apex-frozen-foods-ltd) ₹914 crore · FMCG - Shrimp
2. [Solarworld Energy Solutions Ltd](https://www.sectoralpha.in/stocks/solarworld-energy-solutions-ltd) ₹911 crore · Solar EPC
3. Borosil Scientific Ltd ₹905 crore
4. [Dam Capital Advisors Ltd](https://www.sectoralpha.in/stocks/dam-capital-advisors-ltd) ₹905 crore · Finance - Investment Bankers
5. [Vinsys IT Services India Ltd](https://www.sectoralpha.in/stocks/vinsys-it-services-india-ltd) ₹900 crore · Computer Education

## What else do people ask about Borosil Scientific? ### What is Borosil Scientific's share price today? Borosil Scientific Ltd's share price is ₹106.07, −22.2% over the past year. The whole company is worth ₹941 Cr on the market. In the last 52 weeks it traded between ₹101 to ₹169; today it is 8% of the way up from the low, 17.5% below its 200-day average (as of 3 November 2026). ### What were Borosil Scientific's latest quarterly results? Borosil Scientific Ltd reported revenue of ₹115 Cr and net profit of ₹5.3 Cr for the Sep 2026 quarter. Revenue rose 7.5% and profit rose 86.6% compared with a year earlier. Earnings per share were ₹0.60. The operating margin was 9.3%, 1.8 percentage points higher than a year earlier (as of 3 November 2026). ### What is Borosil Scientific's market cap? Borosil Scientific Ltd's market capitalisation is ₹941 Cr at a share price of ₹106.07. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### What is Borosil Scientific's P/E ratio? Borosil Scientific Ltd's P/E is 20.1×, higher than 1% of its own last 2 years. Its usual level (the middle reading) is 49.2×. This compares the price with the company's own past; it is not a view on what the shares are worth (as of 3 November 2026). ### How is Borosil Scientific valued against its own history? Against its own history, Borosil Scientific Ltd's valuation is low: its P/E of 20.1× has been lower only 1% of the time in 2 years (usual level 49.2×). This compares the price with the company's own past; it is not a view on what the shares are worth or where the price goes next (as of 3 November 2026). ### How is Borosil Scientific performing? Borosil Scientific Ltd's share price has been falling for 5 weeks. In its latest quarter, revenue rose 7.5% and profit rose 86.6% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 15 weeks running (as of 3 November 2026). ### Will Borosil Scientific's share price go up? This page does not forecast Borosil Scientific Ltd's share price. What it shows instead: the share price is ₹106.07, and it has been falling for 5 weeks. Its P/E of 20.1× is higher than 1% of its own last 2 years (as of 3 November 2026). ### Does Borosil Scientific have too much debt? No, Borosil Scientific Ltd has little debt: its debt is 0.02× its equity, and its operating profit is 63 times its interest bill. FY26 borrowings were ₹9.0 Cr against equity of ₹441 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Borosil Scientific in its business cycle? Borosil Scientific Ltd's FY26 operating margin was 14.0%, against a 3-year range of 12.0% to 14.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 9.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Borosil Scientific story? The main question: yearly earnings per share moved +29.2% while the share price moved −22.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Borosil Scientific a stock worth studying right now? What the numbers show: Borosil Scientific Ltd's earnings have grown faster than its share price. Earnings per share grew +29.2% in a year while the price moved −22.2%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.